These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20134488)

  • 1. Diverticular disease: what is the best long-term treatment?
    Tursi A
    Nat Rev Gastroenterol Hepatol; 2010 Feb; 7(2):77-8. PubMed ID: 20134488
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesalazine and rifaximin in symptomatic uncomplicated diverticular disease.
    Festi D; Colecchia A
    Am J Gastroenterol; 2009 Feb; 104(2):532. PubMed ID: 19174809
    [No Abstract]   [Full Text] [Related]  

  • 3. Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease.
    Tursi A; Joseph RE; Streck P
    Dig Dis Sci; 2011 Nov; 56(11):3112-21. PubMed ID: 21567193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverticulitis: new insights on the traditional point of view.
    Moubax K; Urbain D
    Acta Gastroenterol Belg; 2015; 78(1):38-48. PubMed ID: 26118576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.
    Tursi A; Brandimarte G; Daffinà R
    Dig Liver Dis; 2002 Jul; 34(7):510-5. PubMed ID: 12236485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modern indications on the medical treatment of symptomatic diverticular disease].
    Ierfone N; Di Fulvio A; Pontone S; Terzakis P; Martino G; Pontone P
    G Chir; 2006 Mar; 27(3):93-6. PubMed ID: 16681868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights.
    Strate LL; Modi R; Cohen E; Spiegel BM
    Am J Gastroenterol; 2012 Oct; 107(10):1486-93. PubMed ID: 22777341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diverticulosis/diverticulitis? What are conservative therapy possibilities?].
    Rinas U; Adamek HE
    Med Klin (Munich); 2006 Jan; 101(1):49-57; quiz 58-9. PubMed ID: 16418814
    [No Abstract]   [Full Text] [Related]  

  • 9. Mesalazine for diverticular disease of the colon--a new role for an old drug.
    Tursi A
    Expert Opin Pharmacother; 2005 Jan; 6(1):69-74. PubMed ID: 15709884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and evidences for treatment of symptomatic uncomplicated diverticular disease.
    Cuomo R; Cargiolli M; Andreozzi P; Zito FP; Sarnelli G
    Minerva Gastroenterol Dietol; 2017 Jun; 63(2):130-142. PubMed ID: 27973463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of different therapeutic strategies in preventing diverticulitis recurrence.
    Tursi A; Elisei W; Giorgetti GM; Inchingolo CD; Nenna R; Picchio M; Maiorano M; Penna A; Lecca PG; Brandimarte G
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):342-8. PubMed ID: 23426537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease.
    Brandimarte G; Tursi A
    Med Sci Monit; 2004 May; 10(5):PI70-3. PubMed ID: 15114281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifaximin plus fibre versus fibre alone in preventing diverticulitis recurrence: a (problematic) trial to tackle an epidemiologically relevant problem.
    Conte D; Orlando S
    Dig Liver Dis; 2013 Feb; 45(2):102-3. PubMed ID: 23298762
    [No Abstract]   [Full Text] [Related]  

  • 14. Review article: the current and evolving treatment of colonic diverticular disease.
    Tursi A; Papagrigoriadis S
    Aliment Pharmacol Ther; 2009 Sep; 30(6):532-46. PubMed ID: 19549266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of rifaximin on diverticulitis rate and quality of life in patients with diverticulosis.
    Banasiewicz T; Francuzik W; Bobkiewicz A; Krokowicz Ł; Borejsza-Wysocki M; Paszkowski J; Studniarek A; Krokowicz P; Grochowalski M; Szczepkowski M; Lorenc Z
    Pol Przegl Chir; 2017 Feb; 89(1):22-31. PubMed ID: 28522790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review.
    Maconi G; Barbara G; Bosetti C; Cuomo R; Annibale B
    Dis Colon Rectum; 2011 Oct; 54(10):1326-38. PubMed ID: 21904150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic management of acute uncomplicated diverticulitis.
    Fan YC; Peery AF
    Minerva Gastroenterol Dietol; 2017 Jun; 63(2):143-151. PubMed ID: 27990793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing diverticulitis: mesalamine may still be indicated in the decision.
    Floch MH
    Gastroenterology; 2015 Apr; 148(4):856. PubMed ID: 25726738
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotics for Acute Uncomplicated Diverticulitis: Time for a Paradigm Change?
    Peery AF; Stollman N
    Gastroenterology; 2015 Dec; 149(7):1650-1. PubMed ID: 26614249
    [No Abstract]   [Full Text] [Related]  

  • 20. Diverticulosis today.
    Elisei W; Brandimarte G; Tursi A
    Minerva Gastroenterol Dietol; 2019 Mar; 65(1):42-52. PubMed ID: 30293416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.